3

OWNERSHIP DOCUMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: March 28, 2017
Period of Report: March 28, 2017
Accession Number: 0001213900-17-002915

View Document ↗ View on SEC.gov ↗